Necrotizing vasculitis, also called systemic necrotizing vasculitis, is a general term for the inflammation of veins and arteries that develops into necrosis and narrows the vessels.
Tumors, medications, allergic reactions, and infectious organisms are among the recognized triggers for these conditions, though the precise cause of many is unknown. Immune complex disease, anti-neutrophil cytoplasmic antibodies, anti-endothelial cell antibodies, and cell-mediated immunity are examples of pathogenetic factors.
Numerous secondary symptoms of vasculitis can occur, such as blood clots, the formation of weak bulging areas in blood vessel walls (aneurysms), bleeding, blockage (occlusion) of an artery, unintentional weight loss, exhaustion, depression, fever, and widespread pain that worsens in the morning.
Systemic vasculitides are categorized as small, medium, large, or variable based on the diameter of the blood vessel they primarily affect.
Classification Large-vessel vasculitis The 2012 Chapel Hill Consensus Conference defines large vessel vasculitis (LVV) as a type of vasculitis that can affect any size artery, but usually affects the aorta and its major branches more frequently than other vasculitides. Takayasu's arteritis (TA) and giant cell arteritis (GCA) are the two main forms of LVV.
Takayasu's arteritis (TA) is a large-vessel, granulomatous arteritis of unknown cause that primarily affects the aorta, significant branches of it, and (less frequently) the pulmonary arteries. The disease's symptoms can range from catastrophic neurological impairment to an asymptomatic condition brought on by impalpable pulses or bruits. Non-specific features include mild anemia, muscle pain, joint pain, unintentional weight loss, generally feeling unwell, night sweats, and fever.
Giant cell arteritis (GCA) is the most common type of systemic vasculitis in adults. Polymyalgia rheumatica (PMR), headache, jaw claudication, and visual symptoms are the classic manifestations; however, 40% of patients present with a variety of occult manifestations.
Medium vessel vasculitis Medium vessel vasculitis is a type of vasculitis that mostly affects the medium-sized arteries, which are the major arteries that supply the organs and their branches. Any size artery could be impacted, though. The two primary types are polyarteritis nodosa and Kawasaki disease.
Polyarteritis nodosa is a type of systemic necrotizing vasculitis that primarily affects medium-sized arteries. While small vessels like arterioles, capillaries, and venules are not affected, small arteries can be. The disease spectrum varies from failure of multiple organs to involvement of a single organ. Almost any organ can be affected; however, polyarteritis nodosa rarely affects the lungs for unknown reasons.
Kawasaki disease is a type of systemic vasculitis of medium-sized vessels with an acute onset that primarily affects young children. Fever, conjunctivitis, infection of the skin and mucous membranes, and swollen lymph node glands in the neck are the main signs and symptoms.
Small vessel vasculitis Small vessel vasculitis (SVV) is separated into immune complex SVV and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
ANCA-associated vasculitis is a necrotizing vasculitis linked to MPO-ANCA or PR3-ANCA that primarily affects small vessels and has few or no immune deposits. AAV is further classified as eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, and microscopic polyangiitis.
Eosinophilic granulomatosis with polyangiitis is a systemic small-vessel vasculitis linked to eosinophilia and asthma. Polyneuropathy, heart involvement, skin lesions, involvement of the upper respiratory tract, and lung are typical presentations of eosinophilic granulomatosis with polyangiitis.
Granulomatosis with polyangiitis is a rare immune-mediated systemic disease. Its cause is unknown. It manifests pathologically as an inflammatory response pattern in the kidneys, upper and lower respiratory tracts, and granulomatous inflammation, which includes cell death (necrosis).
Microscopic polyangiitis belongs to the group of vasculitides associated with ANCA. Its distinct histology reveals a pauci-immune vasculitis, or necrotizing small vessel vasculitis, with minimal or no immune deposits. The most typical features of microscopic polyangiitis are kidney manifestations and general symptoms; lung involvement is also frequently observed.
Immune complex small vessel vasculitis (SVV) is a vasculitis that primarily affects small vessels and has moderate to significant immunoglobulin and complement component deposits on the vessel wall. Hypocomplementemic urticarial vasculitis, cryoglobulinemic vasculitis, IgA vasculitis, and anti-glomerular basement membrane disease are the categories of immune complex SVV.
Hypocomplementemic urticarial vasculitis syndrome is a rare immune complex-mediated condition involving persistent acquired low levels of complement in the bloodstream and hives. Many systemic manifestations are linked to hypocomplementemic urticarial vasculitis syndrome, such as leukocytoclastic vasculitis, glomerulonephritis, swelling of the larynx, severe angioedema, lung involvement, arthritis, joint pain, and uveitis.
Cryoglobulinemic vasculitis is a type of small-vessel vasculitis that primarily affects the kidneys, skin, joints, and peripheral nervous system. Monoclonal immunoglobulins associated with an underlying B-cell lymphoproliferative disorder are known as type I cryovalent vasculitis. Cryoglobulins type II and III, also known as mixed cryoglobulinemia, are composed of polyclonal immunoglobulin (Ig)G and either monoclonal IgM or both with rheumatoid factor activity. The disease can present with a wide range of symptoms, including fatigue, purpura, or joint pain, to more serious complications, such as glomerulonephritis and widespread vasculitis, which can be fatal.
Immunoglobulin A (IgA) vasculitis, formerly referred to as Henoch–Schönlein purpura, is a type of immune complex vasculitis that primarily affects IgA deposits in small vessels. Acute enteritis, glomerulonephritis, arthralgias and/or arthritis, and cutaneous purpura are the most common clinical manifestations. Children are more likely than adults to develop IgA vasculitis. Adults tend to have a more severe case.
Anti-glomerular basement membrane disease is an uncommon kind of small vessel vasculitis that affects the kidney and lung capillary beds. This illness is also known by its eponym, "Goodpasture syndrome".
Variable vessel vasculitis Variable vessel vasculitis is a kind of vasculitis that may impact vessels of all sizes (small, medium, and large) and any type (arteries, veins, and capillaries), with no particular type of vessel being predominantly affected. This category includes Behçet's disease and Cogan syndrome.
Behçet's disease is a systemic illness marked by frequent episodes of severe inflammation. Genital ulcers, inflammation of the uvea of the eye, oral aphthous ulcers (canker sores), and skin lesions are the main symptoms.
Cogan syndrome is an uncommon type of autoimmune systemic vasculitis that causes inflammation in the eyes and malfunctions the vestibulo-auditory system, usually resulting in neurosensory deafness but also tinnitus and vertigo. An upper respiratory tract infection, or less frequently, diarrhea, a dental infection, or an immunization, precedes the onset of the disease.
History Kussmaul and Maier provided the first detailed description of systemic necrotizing arteritis in 1866.
In 1919 Karl Theodor Fahr described acute arterial lesions which were always present in malignant nephrosclerosis. These injuries were the most severe and widespread in the kidneys and occurred less frequently and severely in other organs, particularly in the pancreas, adrenal glands, and intestines. Fahr believed that necrotizing arteriolitis was the primary cause of the lesions, malignant necrosis, and high blood pressure in these cases by narrowing the kidney vascular bed.
Signs and symptoms Prodromal symptoms, constitutional abnormalities, and organ-specific manifestations are common in vasculitis patients. Patients may show up at the emergency room with life-threatening symptoms (such as coughing up massive amounts of blood or kidney failure) or with nonspecific signs and symptoms (such as a rash, fever, muscle pain, joint pain, a general sense of feeling unwell, or unintentional weight loss) at their family physician's office. The size, location, and extent of the vessels involved all affect the manifestations.
Takayasu's arteritis (TA) is typically documented in three distinct phases. Constitutional inflammatory symptoms are often present during the first stage. Patients may report fever of unknown cause during this phase. Patients may refer to dorsal and thoracic pain in the following phase, and infrequently, neck pain as well. Arterial bruits, intermittent extremity claudication, decreased or absent pulses, and/or variations in arterial blood pressure among upper extremities are the hallmarks of the final phase.
Giant cell arteritis (GCA) often exhibits a wide range of symptoms in its early stages, all of which are related to the localized consequences of systemic and vascular inflammation. The symptoms of GCA include jaw claudication, headaches, and tenderness in the scalp. The most common symptom is headache, which is restricted to the temporal region.
Polyarteritis nodosa (PAN) can affect one organ or cause systemic failure as its clinical manifestation. Although any tissue may be impacted, PAN rarely affects the lungs for unclear reasons. A variety of clinical indicators, including common symptoms like fever, chills, weight loss, myalgia, and arthralgia, are typically present when PAN first manifests. Peripheral nerves and skin are typically involved in PAN. Skin manifestations include purpura, necrotic ulcers, subcutaneous nodules, and livedoid. Mononeuritis multiplex is the main neurological symptom, typically presenting as a drop in the foot or wrist.
Patients with Kawasaki disease often have a fever between 38 and 40 degrees Celsius and often show no prodromal symptoms. Within two to four days of the illness starting, bilateral conjunctival injections without exudate become visible. The term "modifications of the oral cavity" usually refers to conditions such as diffuse erythema of the oropharyngeal mucosa, strawberry-like tongue without vesicles or pseudo-membrane formation, bleeding of the lips, redness, fissuring, and dryness. From the first to the fifth day following the onset of fever, polymorphous erythema appears on the body and/or extremities.
Malaise, joint pain, sinusitis, and rhinitis are typically present at the beginning of Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Prodromes often occur weeks or months before pulmonary-renal syndrome.
Anti-glomerular basement membrane vasculitis patients usually report sudden onset of anuria or oliguria. Typically, hematuria or tea-colored urine are noticed.
Many cases of cryoglobulinemic vasculitis are asymptomatic. Hyperviscosity and/or thrombosis are the principal signs and symptoms of type I cryoglobulinemia. As a result, the conditions most frequently manifested as Raynaud's phenomenon, distal gangrene, ischemic ulcers, purpura, livedo reticularis, headache, retinal hemorrhages, and encephalopathy. Nonspecific systemic and musculoskeletal symptoms, such as cutaneous vasculitis and neuropathy, can also be seen in patients with mixed cryoglobulinemia.
Ninety-five percent of cases of immunoglobulin A vasculitis start with a skin rash. Additionally, the illness manifests as the standard tripartite of symptoms of the gastrointestinal, kidney, and musculoskeletal systems.